• 1. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 2. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 3. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 4. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 5. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389

Quinazoline,4-chloro-2-(4-chlorophenyl)-5-methyl- (CAS No. 885277-78-1): A Comprehensive Overview

Quinazoline derivatives have long been recognized for their significant pharmacological properties, and among these, Quinazoline,4-chloro-2-(4-chlorophenyl)-5-methyl- (CAS No. 885277-78-1) stands out due to its unique structural and functional characteristics. This compound belongs to a class of heterocyclic molecules that have garnered considerable attention in the field of medicinal chemistry. Its molecular structure, featuring a chloro-substituted quinazoline core, makes it a promising candidate for further exploration in drug development.

The Quinazoline,4-chloro-2-(4-chlorophenyl)-5-methyl- scaffold is particularly intriguing because it combines the versatility of the quinazoline ring system with the electron-withdrawing effects of chlorine atoms. This combination not only enhances the compound's reactivity but also influences its interactions with biological targets. The presence of multiple substituents, including a chloro group at the 4-position and a chlorophenyl group at the 2-position, provides multiple sites for functionalization, making it a valuable building block for synthesizing novel derivatives.

In recent years, there has been a surge in research focused on quinazoline derivatives due to their potential applications in treating various diseases. One of the most notable areas of interest is their role in anticancer therapy. Studies have shown that certain quinazoline derivatives can inhibit the growth of cancer cells by targeting specific enzymes and signaling pathways involved in tumor progression. The Quinazoline,4-chloro-2-(4-chlorophenyl)-5-methyl- compound, with its unique structural features, has been investigated for its potential as an anticancer agent.

Research published in peer-reviewed journals has highlighted the compound's ability to interact with key proteins involved in cell proliferation and survival. For instance, studies have demonstrated that it can bind to and inhibit kinases such as EGFR (epidermal growth factor receptor), which are often overexpressed in various types of cancer. The chloro substituents in the molecule are believed to play a crucial role in modulating the binding affinity and selectivity towards these targets.

Moreover, the Quinazoline,4-chloro-2-(4-chlorophenyl)-5-methyl- derivative has shown promise in preclinical studies as an antimicrobial agent. The structural features of this compound allow it to disrupt bacterial cell membranes and interfere with essential metabolic pathways. This has led to investigations into its potential use against multidrug-resistant bacteria, a growing concern in global healthcare.

The synthesis of Quinazoline,4-chloro-2-(4-chlorophenyl)-5-methyl- involves multi-step organic reactions that require careful optimization to ensure high yield and purity. The process typically begins with the condensation of appropriately substituted benzoyl chlorides with amidines or hydrazines to form the quinazoline core. Subsequent functionalization steps introduce the chloro groups and other substituents at specific positions on the ring system.

Advanced spectroscopic techniques such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) are employed to confirm the structural integrity of the compound. These techniques provide detailed information about the chemical environment of each atom in the molecule, ensuring that the synthesized product matches the intended structure.

In addition to its pharmacological applications, Quinazoline,4-chloro-2-(4-chlorophenyl)-5-methyl- has been explored for its potential role in materials science. The unique electronic properties of this compound make it suitable for use in organic semiconductors and light-emitting diodes (LEDs). Researchers have investigated its ability to form stable complexes with other materials, which could lead to novel applications in optoelectronic devices.

The growing interest in quinazoline derivatives has spurred innovation in synthetic methodologies. Recent advancements have focused on developing more efficient and sustainable synthetic routes that minimize waste and reduce environmental impact. Green chemistry principles are being increasingly applied to optimize reactions involving Quinazoline,4-chloro-2-(4-chlorophenyl)-5-methyl-, ensuring that future production processes are both effective and environmentally friendly.

Another area of active research is the development of prodrugs based on quinazoline derivatives. Prodrugs are inactive precursors that are converted into active drugs within the body upon metabolic activation. This approach can enhance drug bioavailability and reduce side effects. The structural flexibility of Quinazoline,4-chloro-2-(4-chlorophenyl)-5-methyl- makes it an ideal candidate for prodrug design.

The pharmacokinetic properties of Quinazoline,4-chloro-2-(4-chlorophenyl)-5-methyl- have been thoroughly studied to understand how it is absorbed, distributed, metabolized, and excreted by the body. These studies provide critical insights into optimizing dosages and delivery methods for therapeutic applications. Advanced computational modeling techniques are often used to predict how different substituents affect these properties.

In conclusion,Quinazoline, CAS No., 885277, 78, 1: Quinazoline, 4-Chloro, 2-(Chorophenyl) - 5-Methyl is a multifaceted compound with significant potential across various fields including medicine and materials science. Its unique structural features make it a valuable tool for researchers exploring new therapeutic agents and advanced materials. As research continues to uncover new applications for this derivative, Quinazoline, CAS No., 885277, -78-, is poised to play an increasingly important role in scientific innovation.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)